Connection

ALEJANDRO ARROLIGA to Hypertension, Pulmonary

This is a "connection" page, showing publications ALEJANDRO ARROLIGA has written about Hypertension, Pulmonary.
Connection Strength

2.233
  1. Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension. Chest. 2007 Jan; 131(1):109-17.
    View in: PubMed
    Score: 0.195
  2. Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan. South Med J. 2006 Aug; 99(8):880-3.
    View in: PubMed
    Score: 0.189
  3. Surgical intervention in patients with moderate to severe pulmonary arterial hypertension. Conn Med. 2006 Apr; 70(4):239-43.
    View in: PubMed
    Score: 0.185
  4. Hypothyroidism and pulmonary arterial hypertension. Am J Med. 2004 Mar 01; 116(5):354-5.
    View in: PubMed
    Score: 0.160
  5. Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension. Drugs Today (Barc). 2004 Mar; 40(3):225-34.
    View in: PubMed
    Score: 0.160
  6. Association between hyperhomocysteinemia and primary pulmonary hypertension. Respir Med. 2003 Jul; 97(7):825-9.
    View in: PubMed
    Score: 0.153
  7. Nocturnal hypoxemia is common in primary pulmonary hypertension. Chest. 2001 Sep; 120(3):894-9.
    View in: PubMed
    Score: 0.135
  8. Primary pulmonary hypertension and thyroid disease. Chest. 2000 Oct; 118(4):1224-5.
    View in: PubMed
    Score: 0.126
  9. Primary pulmonary hypertension: update on pathogenesis and novel therapies. Cleve Clin J Med. 2000 Mar; 67(3):175-8, 181-5, 189-90.
    View in: PubMed
    Score: 0.121
  10. High prevalence of hypothyroidism in patients with primary pulmonary hypertension. Am J Med Sci. 1999 Nov; 318(5):289-92.
    View in: PubMed
    Score: 0.119
  11. Airway responsiveness to inhaled albuterol in patients with pulmonary hypertension. Clin Pediatr (Phila). 1999 Jan; 38(1):27-33.
    View in: PubMed
    Score: 0.112
  12. Manifestations of scleroderma pulmonary disease. Clin Chest Med. 1998 Dec; 19(4):713-31, viii-ix.
    View in: PubMed
    Score: 0.111
  13. Circulating miRNAs as potential marker for pulmonary hypertension. PLoS One. 2013; 8(5):e64396.
    View in: PubMed
    Score: 0.076
  14. Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension. Clin Transl Sci. 2008 Sep; 1(2):99-106.
    View in: PubMed
    Score: 0.055
  15. Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia. Chest. 2007 Apr; 131(4):984-7.
    View in: PubMed
    Score: 0.050
  16. Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. Free Radic Biol Med. 2004 Oct 01; 37(7):1010-7.
    View in: PubMed
    Score: 0.042
  17. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J. 2004 Nov; 18(14):1746-8.
    View in: PubMed
    Score: 0.042
  18. Diagnosis and evaluation of pulmonary hypertension. Cleve Clin J Med. 2003 Apr; 70 Suppl 1:S9-17.
    View in: PubMed
    Score: 0.038
  19. Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension. Cleve Clin J Med. 2003 Apr; 70 Suppl 1:S18-27.
    View in: PubMed
    Score: 0.038
  20. Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive. Clin Immunol. 2002 Aug; 104(2):191-8.
    View in: PubMed
    Score: 0.036
  21. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung. 2001; 179(4):233-43.
    View in: PubMed
    Score: 0.032
  22. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med. 1998 Sep; 158(3):917-23.
    View in: PubMed
    Score: 0.027
  23. Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci U S A. 2007 Jan 23; 104(4):1342-7.
    View in: PubMed
    Score: 0.012
  24. Exacerbation of underlying pulmonary disease in pregnancy. Crit Care Med. 2005 Oct; 33(10 Suppl):S313-8.
    View in: PubMed
    Score: 0.011
  25. Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol. 1999 Sep; 21(3):311-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.